Genome Surgery & Neuronal Disorders

Genome surgery using CRISPR genomic techniques offer the potential to correct disease-causing mutations in many neuronal disorders. Here are the latest discoveries pertaining to genome surgery and neuronal disorders.

June 20, 2020
Open Access

Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders

Neurologia i neurochirurgia polska
Massimo S FiandacaKrystof S Bankiewicz
June 18, 2020
Open Access

Arginine-Modified Polymers Facilitate Poly (Lactide-Co-Glycolide)-Based Nanoparticle Gene Delivery to Primary Human Astrocytes

International Journal of Nanomedicine
Jessica ProulxKathleen Borgmann
April 7, 2020
Open Access

Gene Therapy Approach for Intervertebral Disc Degeneration: An Update

Neurospine
Yoshiki TakeokaKotaro Nishida
June 2, 2020

Fluorogenic detection of protein aggregates in live cells using the AggTag method

Methods in Enzymology
Kwan Ho Jung, Xin Zhang
March 27, 2020
Review

Intravitreal stem cell paracrine properties as a potential neuroprotective therapy for retinal photoreceptor neurodegenerative diseases

Neural Regeneration Research
Kevin Puertas-NeyraIvan Fernandez-Bueno
July 3, 2020

Impact of multiple sclerosis risk loci in postinfectious neurological syndromes

Multiple Sclerosis and Related Disorders
Filippo Martinelli-BoneschiEnrico Marchioni
March 29, 2020
Review
Open Access

Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases

Frontiers in Veterinary Science
Brett D StoryHeather L Gray-Edwards
May 2, 2020
Open Access

Replication analysis of variants associated with multiple sclerosis risk

Scientific Reports
Mohammad DashtiRabeah Al-Temaimi
June 27, 2020
Review
Open Access

Klotho and the Treatment of Human Malignancies

Cancers
Aishani SachdevaIrene Chong
March 20, 2020
Review
Open Access

Mucopolysaccharidosis Type I

Diagnostics
Francyne KubaskiRoberto Giugliani
May 1, 2020
Review
Open Access

Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases

Frontiers in Molecular Biosciences
Jacob M FavretDaesung Shin
May 2, 2020
Open Access

Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?

Molecular Therapy. Methods & Clinical Development
Karim BeyMarie-Anne Colle
March 14, 2020

A method for gene knockdown in the retina using a lipid-based carrier

Molecular Vision
Joshua A Chu-TanRiccardo Natoli
March 18, 2020
Review
Open Access

Gene-selective treatment approaches for Huntington's disease

Der Nervenarzt
A MühlbäckG B Landwehrmeyer

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

© 2020 Meta ULC. All rights reserved
/feed-previews/genome-surgery-neuronal-disorders/46af9a03-6bab-45f4-a4c4-2f46679f9852